Home
>
National Drug Code (NDC)
>
Catapres
Catapres - 0597-0011-01 - (clonidine hydrochloride)
Drug Information of Catapres
| Product NDC: | 0597-0011 |
| Proprietary Name: | Catapres |
| Non Proprietary Name: | clonidine hydrochloride |
| Active Ingredient(s): | .3 mg/1 & nbsp; clonidine hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Catapres
| Product NDC: | 0597-0011 |
| Labeler Name: | Boehringer Ingelheim Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017407 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19990501 |
Package Information of Catapres
| Package NDC: | 0597-0011-01 |
| Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (0597-0011-01) |
NDC Information of Catapres
| NDC Code | 0597-0011-01 |
| Proprietary Name | Catapres |
| Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (0597-0011-01) |
| Product NDC | 0597-0011 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | clonidine hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19990501 |
| Marketing Category Name | NDA |
| Labeler Name | Boehringer Ingelheim Pharmaceuticals Inc. |
| Substance Name | CLONIDINE HYDROCHLORIDE |
| Strength Number | .3 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |
